Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies
Conditions
- Acute Myeloid Leukemia in Remission
- Adult Acute Lymphoblastic Leukemia in Remission
- Chronic Myelogenous Leukemia (CML)
- Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial Remission
- Chronic Lymphocytic Leukemia (CLL)
- Multiple Myeloma (MM)
- Myelodysplastic Syndrome (MDS)
- Myeloproliferative Disorders
Interventions
- DRUG: POL6326
- PROCEDURE: Leukapheresis
- PROCEDURE: PBSC Transplant
Sponsor
Polyphor Ltd.